2022
DOI: 10.1016/j.jcct.2022.07.002
|View full text |Cite
|
Sign up to set email alerts
|

CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 155 publications
(11 citation statements)
references
References 58 publications
1
10
0
Order By: Relevance
“…The prevalence of CAFs differs based on the study group, diagnostic methods, and applied definitions. To our knowledge, our report represents the largest computed tomographic study to date in adults, and the CAF prevalence of 0.11% is in line with the previous tomographic and angiographic studies [3][4][5][6][19][20][21].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…The prevalence of CAFs differs based on the study group, diagnostic methods, and applied definitions. To our knowledge, our report represents the largest computed tomographic study to date in adults, and the CAF prevalence of 0.11% is in line with the previous tomographic and angiographic studies [3][4][5][6][19][20][21].…”
Section: Discussionsupporting
confidence: 90%
“…The presence and severity of atherosclerotic lesions in coronary arteries were assessed according to the Coronary Artery Disease -Reporting and Data System (CAD-RADS), which ranges from CAD-RADS 0 (no atherosclerosis) to CAD-RADS 5 (total occlusion in at least one vessel) [19].…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, in our classification, they are gathered under the same concept of potentially symptomatic. Unlike Rigatelli et al's 4 classification, our classification excludes the association between coronary anomalies and atherosclerotic coronary disease, due to its appropriate analysis using the CAD-RADS™ 2.0 reporting system 44 and the E modifier, making this association a separate entity, which includes the study of plaque in coronary disease and nonatherosclerotic stenosis within a single system.…”
Section: Discussionmentioning
confidence: 99%
“…Coronary artery disease-reporting and data system (CAD-RADS) [ 31 ] aims to improve the accuracy of diagnosing and managing CAD patients. The updated 2022 CAD-RADS 2.0 classification [ 32 ] includes new elements such as plaque burden and ischemia evaluation, enabling the integration of CT-FFR or myocardial CT perfusion (CTP) data; moreover it introduces modifiers like coronary stents, high-risk plaque features, ischemia test results, and the "P" designation to classify plaque severity, based on CAC, SIS, and Visual scoring for plaque categorization [ 32 ]. Using a scale from 0 to 5, it grades coronary artery stenosis observed in CCTA images.…”
Section: Atherosclerotic Burdenmentioning
confidence: 99%